CVS Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy LeadershipConsistently high specialty adherence (>90%) is a durable competitive advantage: it strengthens relationships with payers and manufacturers, supports higher-margin specialty dispensing and clinical services, and increases patient stickiness and long-term revenue visibility in specialty care.
Improving Cash Generation And DeleveragingSubstantial free cash flow and declining debt represent durable financial strength: higher FCF and lower leverage improve flexibility to fund tech investments, sustain dividends, and absorb reimbursement volatility, while reducing interest burden and supporting multi-year strategic initiatives.
Large Tech & AI Investment Unlocking EfficienciesA multi-decade technology commitment and early >$1B OpEx savings indicate structural productivity gains: AI-enabled claims and automation improve processing speed and margins, strengthen PBM/retail differentiation, and create sustainable operating leverage across the enterprise.
Bears Say
Compressed Profitability & Low ROEVery low margins and depressed return on equity reflect weaker earnings quality and less capacity to generate returns from the asset base. This structural profitability compression limits reinvestment capacity, reduces resilience to pricing/regulatory shocks, and constrains long-term shareholder returns.
340B Program HeadwindsOngoing 340B disruptions and manufacturer restrictions are a structural revenue and margin risk for related pharmacy services. Prolonged uncertainty can reduce specialty and contract pharmacy economics, hinder Caremark spreads, and impair medium‑term earnings visibility.
Anticipated Caremark Membership DeclinesExpected PBM membership declines reflect durable client contract repricing and shifts to lowest net cost models. Loss of scale reduces negotiating leverage, pressures purchasing economics and spreads, and can materially dampen Health Services revenue and margin over multiple quarters.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
Currently, no data Available
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is CHF99.31B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Nov 04, 2026 which is in 84 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Aug 05, 2026. The company reported CHF2.094 earnings per share for the quarter, beating the consensus estimate of CHF1.505 by CHF0.589.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp does not currently pay dividends.
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.34.
How many shares outstanding does CVS Health Corp have?
Currently, no data Available
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of CHF2.094 in its last earnings report, beating expectations of CHF1.505. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CH:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF92.13 (― Upside)
CHF92.13 (― Upside)
Blogger Sentiment
Bullish
CH:CVS Sentiment 81%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth CHF261.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 92%
Bearish news 8%
Bearish news 8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.21%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.77%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum across segments with material upside: double-digit growth in operating income, raised EPS guidance, improved cash flow outlook, specialty leadership, and early tangible AI-driven efficiencies. Offsetting these positives are notable industry-specific headwinds—most prominently near-term 340B pressures, anticipated Caremark membership declines in 2027, ongoing reimbursement and regulatory pressures, and some timing-related pull-forwards. Management emphasized disciplined execution, balance sheet improvement and a multi-year growth outlook (mid-teens EPS CAGR through 2028), while acknowledging and preparing for specific near-term headwinds.View all CH:CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
